SBC / revenue moved 28610 bp higher
SBC / revenue changed +28610 basis points from the comparable as-filed period.
277.16%→563.26%3 prior comparisons
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
SBC / revenue changed +28610 basis points from the comparable as-filed period.
Research & development changed -4.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Net income changed +0.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.